Barclays PLC Rigel Pharmaceuticals Inc Transaction History

Barclays PLC

  • $377 Billion
  • Q3 2024

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
SELL
$0.79 - $9.53 $110,596 - $1.33 Million
-139,995 Reduced 92.98%
10,573 $88,000
Q1 2024

May 15, 2024
SELL
$1.12 - $1.57 $107,447 - $150,617
-95,935 Reduced 38.92%
150,568 $223,000
Q4 2023

Feb 15, 2024
BUY
$0.72 - $1.56 $147,495 - $319,573
204,855 Added 491.87%
246,503 $357,000
Q3 2023

Nov 07, 2023
SELL
$1.07 - $1.39 $4,117 - $5,348
-3,848 Reduced 8.46%
41,648 $45,000
Q2 2023

Aug 03, 2023
SELL
$1.12 - $1.82 $59,597 - $96,845
-53,212 Reduced 53.91%
45,496 $59,000
Q1 2023

May 04, 2023
BUY
$1.25 - $2.0 $65,465 - $104,744
52,372 Added 113.03%
98,708 $131,000
Q4 2022

Feb 13, 2023
BUY
$0.67 - $11.9 $26,142 - $464,326
39,019 Added 533.26%
46,336 $69,000
Q3 2022

Nov 03, 2022
SELL
$1.1 - $12.2 $1,478 - $16,396
-1,344 Reduced 15.52%
7,317 $9,000
Q2 2022

Aug 12, 2022
SELL
$0.67 - $3.19 $26,710 - $127,175
-39,867 Reduced 82.15%
8,661 $10,000
Q1 2022

May 16, 2022
SELL
$2.22 - $3.45 $352,662 - $548,056
-158,857 Reduced 76.6%
48,528 $145,000
Q4 2021

Feb 14, 2022
SELL
$2.36 - $3.57 $353,667 - $534,996
-149,859 Reduced 41.95%
207,385 $550,000
Q3 2021

Nov 09, 2021
BUY
$3.5 - $4.5 $422,772 - $543,564
120,792 Added 51.09%
357,244 $1.3 Million
Q2 2021

Aug 13, 2021
SELL
$3.09 - $4.54 $579,285 - $851,118
-187,471 Reduced 44.22%
236,452 $1.03 Million
Q1 2021

May 13, 2021
BUY
$3.35 - $4.93 $904,620 - $1.33 Million
270,036 Added 175.48%
423,923 $1.45 Million
Q4 2020

Feb 11, 2021
SELL
$2.35 - $3.74 $71,468 - $113,740
-30,412 Reduced 16.5%
153,887 $538,000
Q3 2020

Nov 12, 2020
SELL
$1.78 - $4.13 $115,094 - $267,045
-64,660 Reduced 25.97%
184,299 $441,000
Q2 2020

Aug 12, 2020
BUY
$1.41 - $2.05 $57,110 - $83,033
40,504 Added 19.43%
248,959 $456,000
Q1 2020

May 13, 2020
SELL
$1.27 - $3.0 $47,315 - $111,768
-37,256 Reduced 15.16%
208,455 $325,000
Q4 2019

Feb 10, 2020
BUY
$1.6 - $2.43 $57,945 - $88,004
36,216 Added 17.29%
245,711 $526,000
Q3 2019

Nov 14, 2019
BUY
$1.63 - $2.62 $65,817 - $105,792
40,379 Added 23.88%
209,495 $392,000
Q2 2019

Aug 14, 2019
BUY
$2.02 - $2.61 $123,230 - $159,223
61,005 Added 56.43%
169,116 $442,000
Q1 2019

May 15, 2019
BUY
$2.0 - $2.65 $16,024 - $21,231
8,012 Added 8.0%
108,111 $278,000
Q4 2018

Feb 14, 2019
SELL
$2.08 - $3.36 $352,468 - $569,372
-169,456 Reduced 62.87%
100,099 $230,000
Q3 2018

Nov 14, 2018
SELL
$2.6 - $3.59 $820,430 - $1.13 Million
-315,550 Reduced 53.93%
269,555 $866,000
Q2 2018

Aug 14, 2018
SELL
$2.83 - $4.11 $966,628 - $1.4 Million
-341,565 Reduced 36.86%
585,105 $1.66 Million
Q1 2018

May 15, 2018
BUY
$3.54 - $4.54 $1.77 Million - $2.27 Million
500,679 Added 117.53%
926,670 $3.28 Million
Q4 2017

Feb 14, 2018
BUY
$3.23 - $4.3 $832,351 - $1.11 Million
257,694 Added 153.12%
425,991 $1.65 Million
Q3 2017

Nov 14, 2017
BUY
$2.18 - $2.57 $366,887 - $432,523
168,297
168,297 $427,000

Others Institutions Holding RIGL

# of Institutions
8
Shares Held
334K
Call Options Held
0
Put Options Held
0
View Full List

About RIGEL PHARMACEUTICALS INC

RIGL Quotes by TradingView
  • Ticker RIGL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 172,836,000
  • Market Cap $2.95B
  • Description
  • Rigel Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs to treat hematologic disorders, cancer, and rare immune diseases. The company offers Tavalisse, an oral spleen tyrosine kinase inhibitor for the treatment of adult patients with chronic immune thrombocytopenia. It also develops Fostamatinib that is ...
More about RIGL
Track This Portfolio

Track Barclays PLC Portfolio

Follow Barclays PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email